Drug application
CITANEST (PRILOCAINE HYDROCHLORIDE)
Drugs@FDA NDA 014763 · ASTRAZENECA
Key facts
| Drug name | CITANEST |
|---|---|
| Active ingredients | PRILOCAINE HYDROCHLORIDE |
| Application type | NDA |
| Application number | 014763 |
| Company | ASTRAZENECA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Nov 18, 1965 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.